A major reversal on long-held view of low-dose aspirin’s heart benefits
Aspirin has gotten its crown knocked askew as a cheap, effective low-dose heart problem preventer for older Americans.
That’s because the U.S. Preventive Services Task Force has weighed the evidence, heard the comments, and recommended against patients 60 and older taking the common drug to avert cardiovascular diseases. The experts gave this purportedly protective step a “D” grade.
The USPSTF is an elite, independent, and influential group of experts who advise the federal government, insurers, and clinicians about the safety and effectiveness of medical tests and procedures based on rigorous consideration of their merits.